News

News
Loading…Load More

  • Ajinomoto Althea, Inc. Expands Manufacturing Capabilities to ADC Fill Finish and Bioconjugation

  • Ajinomoto Althea, Inc. Awarded CA Tax Credit

  • Ajinomoto Althea, Inc. Receives European GMP Certification for Commercial Aseptic Filling and Testing

  • Althea’s New Drug Formulation Technology Gains Attention from Two More Top Pharmaceutical Companies

  • Ajinomoto Althea, Inc. Receives European GMP Certification

  • Ajinomoto Althea Inc. Now Offering A Novel Protein Production Platform: Corynex®

  • Ajinomoto Althea Inc. Appoints J. David Enloe as President and Chief Executive Officer

  • Ajinomoto Althea, Inc. Selected as a Finalist in 26th Annual CONNECT Most Innovative New Product Awards

  • Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc

  • Ajinomoto Co., Inc. Agrees to Acquire Althea Technologies, Inc.

  • Althea Technologies & Profectus Biosciences Sign Manufacturing Agreement for Plasmid DNA Production

  • Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen